ANSM Safety Information: Thoraflex Hybrid Thoracic Aorta Prosthesis
Summary
The French National Agency for Medicines and Health Products Safety (ANSM) has issued a safety alert regarding the Thoraflex Hybrid thoracic aorta prosthesis manufactured by Vascutek Ltd. Healthcare providers have been notified of a safety action implemented by the manufacturer.
What changed
The ANSM has been informed by Vascutek Ltd. of a safety action concerning their Thoraflex Hybrid thoracic aorta prosthesis. This action is registered under ANSM reference R2608253. Healthcare facilities have received direct communication from the manufacturer regarding this safety measure, and a link to the manufacturer's letter dated March 23, 2026, is provided.
Healthcare providers receiving this notice should review the manufacturer's communication carefully to understand the specific actions required or recommended. For any questions or further details, they should contact Vascutek Ltd. directly, as indicated by the ANSM. The provided link to the manufacturer's letter offers the most detailed information on the nature of the safety action and any necessary steps.
What to do next
- Review communication from Vascutek Ltd. regarding the Thoraflex Hybrid prosthesis safety action.
- Contact Vascutek Ltd. directly for any questions or clarification.
Archived snapshot
Mar 23, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Information n° R2608253 destinée aux établissements de santé L'ANSM a été informée de la mise en œuvre d’une action de sécurité effectuée par la société Vascutek Ltd.
Les utilisateurs concernés ont reçu le courrier ci-joint.
Cette action de sécurité est enregistrée à l’ANSM sous le n° R2608253. Pour toute question, merci de vous adresser directement à l’émetteur de l’action de sécurité. Téléchargez le courrier de la société Vascutek Ltd (23/03/2026)
Related changes
Get daily alerts for ANSM Drug & Device Safety Alerts
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from ANSM.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ANSM Drug & Device Safety Alerts publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.